United States Antimony: Weak Pricing, Stronger Volumes, And A Government Catalyst

GT Research 134 Followers Follow Summary United States Antimony is rated Buy, with a $10-11 target, as the market overreacts to weak antimony prices and trailing revenue. Q2 volumes rose 26% YoY despite a 52% drop in realized antimony prices, indicating operational strength masked by commodity headwinds. A $245M government contract is ramping up, with revenue conversion just beginning and significant upside potential as deliveries accelerate. UAMY's $105M in cash and investments, minimal debt, and a $100M buyback program provide flexibility and downside protection during the ramp. BJP7images/iStock via Getty Images Investment Thesis United States Antimony ( UAMY ) just had a rough quarter . Revenue was missed by almost $14 million, the company cut its full-year guidance, and the stock now sits around $4.68, close to the low end of a 52-week This article was written by GT Research 134 Followers Follow I have a strong interest in fundamental equity research, with a focus on companies with smaller market capitalizations. I look for underfollowed or misunderstood businesses with solid fundamentals, attractive long-term potential, and valuations that may not fully reflect their prospects.My approach emphasizes business quality, financial performance, management, capital allocation, valuation, and downside risk. I write on Seeking Alpha to share independent investment ideas, refine my research, and engage with other investors.Closely associated with Rafael Binatti Costa. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.